Diabetes Registry Graz for Biomarker Research
Launched by MEDICAL UNIVERSITY OF GRAZ · Apr 5, 2022
Trial Information
Current as of July 25, 2025
Recruiting
Keywords
ClinConnect Summary
The Diabetes Registry Graz for Biomarker Research is a study designed to better understand diabetes and related conditions, such as obesity and lipid disorders. Researchers are looking to collect important information, blood, and urine samples from people with different types of diabetes, including type 1, type 2, and rarer forms, over several years. This information will help scientists find new ways to improve treatment and management of these conditions.
To join this study, participants need to be between 18 and 99 years old and must agree to take part by signing a consent form. They should have one of the following conditions: type 1 diabetes, type 2 diabetes, specific rare types of diabetes, obesity (defined as a body mass index over 30), or issues with fat metabolism. If you decide to participate, you can expect to provide data and samples once a year. This is a fantastic opportunity to contribute to important research that may help others in the future!
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 18 - 99 years
- • Informed consent has to be given in written form
- * At least one of the following diseases:
- • Type 1 diabetes
- • Type 2 diabetes
- • Type 3 diabetes
- • Maturity onset diabetes of young (MODY)
- • Late onset diabetes of the adult (LADA)
- • Adipositas (BMI \> 30kg/m2)
- • Lipid metabolism disorder
- Exclusion Criteria:
- • No written informed consent
- • No willingness to participate in this registry
About Medical University Of Graz
The Medical University of Graz, a leading institution in Austria, is dedicated to advancing medical knowledge and improving patient care through innovative research and clinical trials. Renowned for its interdisciplinary approach, the university collaborates with various healthcare professionals and researchers to explore cutting-edge therapies and treatments. With a commitment to ethical standards and patient safety, the Medical University of Graz actively contributes to the global medical community by facilitating rigorous clinical trials that aim to translate scientific discoveries into practical applications for improved health outcomes.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Graz, , Austria
Patients applied
Trial Officials
Harald Sourij, MD
Principal Investigator
Medical University of Graz
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials